Germany · Delayed Price · Currency is EUR Cherry SE Earnings Call Transcripts
Fiscal Year 2026
-
Revenue grew 3% year-over-year to EUR 40 million, with adjusted EBITDA loss narrowing to EUR 4 million and gross margin rising to 45.1%. Project Blossom and regional strategies target breakeven at EUR 85 million revenue and 44% margin by 2027, while Digital Health divestment and cost reductions remain key priorities.
-
Q1 2026 showed operational improvements, with strong DH&S growth and improved EBITDA margin despite lower revenue. Project Blossom targets profitability through cost reduction and focused growth, while a reverse share split and potential business unit sale aim to strengthen capital structure.
Fiscal Year 2024
-
H1 2024 saw improved profitability and strong growth in Digital Health, offsetting declines in other segments. Inventory and cost controls strengthened the balance sheet, while guidance for FY 2024 is maintained despite macroeconomic headwinds and logistical risks.